Celanese Corporation Class A Aktie News

DALLAS--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced Kim K.W. Rucker as its new lead independent director effective April 18, 2024. Ms. Rucker, former Executive Vice President, General Counsel and Corporate Secretary for Andeavor (formerly Tesoro Corp.) and experienced corporate director, has been a member of the Celanese B...

DALLAS--(BUSINESS WIRE)--Celanese to Hold First Quarter Earnings Conference Call on May 9, 2024.

DALLAS--(BUSINESS WIRE)--Celanese Corporation Declares Quarterly Dividends of $0.70 Per Share.

DALLAS & MORRISTOWN, N.J.--(BUSINESS WIRE)---- $CE--Chemical Marketing & Economics Honors Celanese Chairman, CEO and President Lori J. Ryerkerk with STEM Leadership Award for Corporate Reinvention.

DALLAS & SHANGHAI--(BUSINESS WIRE)---- $CE--Celanese Completes Series of Strategic Actions Across its Global Acetyl Chain.

DALLAS--(BUSINESS WIRE)---- $CE--Celanese Achieves ISCC CFC Certification for Low Carbon CCU Methanol.

DALLAS, TX and MARTINSRIED, GERMANY / ACCESSWIRE / March 20, 2024 / Celanese Corporation (NYSE:CE), a global specialty materials and chemical company, and Secarna Pharmaceuticals GmbH & Co. KG, a leading independent European antisense drug discovery and development company, today announced a research collaboration for the development of long-acting implants that deliver antisense oligonucleotid...

DALLAS & MARTINSRIED, Germany--(BUSINESS WIRE)---- $CE--Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies.